# Xenazine

NDC: 67386-421
Generic name: tetrabenazine
Labeler / Manufacturer: Lundbeck Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20081124

FDA application: NDA021894

## Active ingredients

- TETRABENAZINE: 12.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67386-421"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67386-421
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ac768bab-8afa-4446-bc7f-caeeffec0cda